Innovation Pharmaceuticals Inc (IPIX)

[olden_grumpini]

Go to page 9 of the GMU paper, Figure 5B and Figure 5C. It shows the results of testing for brilacidin and remdesivir separately and in combination. Identical conditions. There you will see that remdesivir reduced the viral titer by 99% by itself while brilacidin reduced it by 90%.

IPIX issued a press release about this testing but only mentioned the combination of brilacidin and remdesivir achieving nearly 100%. It's only when reading the GMU data that you see remdesivir was 99% by itself.

I grant that brilacidin has a different MOA, but the testing done by GMU shows that when they tested the two drugs under identical conditions remdesivir was a more potent antiviral than brilacidin.

Here's the GMU paper published in viruses: Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Here's the IPIX press release: Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent